Back to search

Article

Analyzing human knockouts to validate GPR151 as a therapeutic target for reduction of body mass index

2021-10-26

Abstract excerpt

Novel drug targets for sustained reduction in body mass index (BMI) are needed to curb the epidemic of obesity, which affects 650 million individuals worldwide and is a causal driver of cardiovascular and metabolic disease and mortality. Previous studies reported that the Arg95Ter nonsense variant of GPR151, an orphan G protein-coupled receptor, is associated with reduced BMI and reduced risk of Type 2 Diabetes (T...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b82646ac-186d-5c10-9c9b-82c89ebcbd6b
DOI
10.1101/2021.10.21.21264378
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Analyzing human knockouts to validate GPR151 as a therapeutic target for reduction of body mass indexDOI 10.1101/2021.10.21.21264378
Select a neighboring publication to make it the new centre.